Compare CALX & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CALX | TWST |
|---|---|---|
| Founded | 1999 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.0B |
| IPO Year | 2009 | 2018 |
| Metric | CALX | TWST |
|---|---|---|
| Price | $50.52 | $46.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $74.75 | $48.75 |
| AVG Volume (30 Days) | 1.1M | ★ 1.2M |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.78 | 63.89 |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $510,367,000.00 | $376,572,000.00 |
| Revenue This Year | $16.40 | $18.89 |
| Revenue Next Year | $13.75 | $15.28 |
| P/E Ratio | $200.15 | ★ N/A |
| Revenue Growth | 11.24 | ★ 20.32 |
| 52 Week Low | $28.61 | $23.30 |
| 52 Week High | $71.22 | $57.88 |
| Indicator | CALX | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 43.04 | 50.07 |
| Support Level | $45.38 | $25.67 |
| Resistance Level | $56.17 | $57.88 |
| Average True Range (ATR) | 2.45 | 3.03 |
| MACD | -0.13 | -0.69 |
| Stochastic Oscillator | 1.53 | 26.15 |
Calix Inc develops, markets and sells its appliance-based platform, cloud and managed services that enable service providers of all types and sizes to innovate and transform their businesses. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.